arrow
G

Guido Stirnimann

University of Bern
H指数:24
被引数:2,289

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatitis E Virus Infection in Swiss Transplant Recipients: Seroprevalence, Incidence, and the Role of Transfused Blood Products

瑞士移植受者中的戊型肝炎病毒感染:血清流行率、发病率和输注血液制品的作用

2026-09-250
OAAI
Stage-dependent Effects of Systemic ASBT Inhibition in a Cholestasis-induced Cholemic Nephropathy Mouse Model

系统ASBT抑制在胆汁淤积诱导的胆汁性肾病小鼠模型中的阶段依赖性效应

2025-09-230
OAAI
Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors

Ghallab A, Mandorfer M, Stirnimann G, Geyer J, Lindström E, Luedde T, et al. 肠-肾-肝胆汁酸循环及系统性胆汁酸转运体抑制剂的 therapeutic potential. J Hepatol. 2025. S0168-8278(25)02207-X. doi:10.1016/j.jhep.2025.05.009 Epub ahead of print. PMID: 40414504. Cited Here | Google Scholar

2025-05-230
OAAI
Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis
2024-02-0121
OAAI
Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial)
2023-08-167
OAAI
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans

基于串联质量标签的定量蛋白质组学分析可确定人类药物性肝损伤的候选血清生物标志物

2023-03-0315
OAAI
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry

推进药物性肝损伤研究的新框架。未来的欧洲帝力登记处

2022-08-1538
OAAI